Medicamen Biotech

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue40.8843.2245.0345.5542.06
Expenses35.7339.2241.0341.8339.04
EBITDA7.796.716.427.365.43
EBIT6.114.914.665.603.70
Profit Before Tax5.164.004.013.723.02
Net Profit4.423.012.773.102.26
Financial Ratios
Operating Profit Margin19.23%15.70%14.52%16.37%13.11%
Net Profit Margin10.91%7.05%6.27%6.89%5.45%
Earning Per Share (Diluted)3.492.382.192.451.78
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.3.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ